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Previewscaspase-11-mediated cytotoxicity is also
currently unknown. While TLR4-TRIF-IF-
NAR signaling upregulates caspase-11
expression and induces its processing,
treatment with LPS or type I IFN alone
does not trigger caspase-11-dependent
cytotoxicity. An additional sensor, which
might itself be type I IFN dependent or
independent, that responds to specific
features of bacterial infection might also
be required to induce caspase-11-depen-
dent cell death.
Intriguingly, while caspase-1 can
mediate cell death downstream of canon-
ical inflammasomes, caspase-1 is dis-
pensable for caspase-11-dependent cell
death. Whether caspase-1 and caspase-
11 trigger cell death in the same way
therefore remains an open question,
and indeed, precisely how caspase-1 or
caspase-11 induces cell death is alsoenigmatic. Together, these new studies
shed light on additional signals that acti-
vate caspase-11 during bacterial infection
and establish caspase-11-dependent cell
death as an important effector mecha-
nism for responding to bacterial patho-
gens that access the host cell cytosol.REFERENCES
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Host lipid alterations are centrally involved in Leishmania donovani infection, and infected patients exhibit
hypocholesterolemia. In this issue of Cell Host & Microbe, Ghosh et al. (2013) show that the metalloprotease
GP63 released by L. donovani in the liver cleaves DICER1, inhibiting miR-122 maturation, which regulates
cholesterol metabolism. These events decrease serum cholesterol and promote parasite growth.Protozoan parasites of the genus Leish-
mania are responsible for a spectrum
of human diseases, ranging from self-
healing ulcers to potentially fatal visceral
leishmaniasis (VL), which affect millions
of people worldwide. The parasites are
transmitted to mammals in the promasti-
gote form by infected sand flies. Following
phagocytosis by macrophages, promas-
tigotes differentiate into amastigotes, the
mammalian stage of the parasite, and
replicate inside phagolysosomal com-
partments. Leishmania donovani, the
causative agent of VL, disseminates and
multiplies within mononuclear phago-
cytes of the reticuloendothelial system,
including the liver, spleen, lymph nodes,
and bone marrow. VL can remain asymp-tomatic or subclinical or may take an
acute or chronic course. Heavily infected
patients may develop disease after an
incubation period varying from weeks to
months. Fever and hepatosplenomegaly
are common symptoms. In addition, VL
patients suffer from progressive weight
loss, cachexia, and pancytopenia. Recent
clinical evidence pointed toward an alter-
ation of lipid metabolism in VL patients,
characterized by a marked hypocholes-
terolemia and reduced LDL cholesterol
(Lal et al., 2007).
In this issue, Ghosh and colleagues
(Ghosh et al., 2013) unveil the mecha-
nism(s) responsible for alteration of
cholesterol metabolism in experimental
VL. Cholesterol is an essential lipid forthe life of eukaryotic cells. It is a major
component of biomembranes, as it regu-
lates their fluidity and structural stability
and maintenance. Cholesterol plays
central roles in processes ranging from
signal transduction to hormone synthesis
(Simons and Ikonen, 2000). In addition, it
is involved in inflammation and infectious
disease. Cholesterol biogenesis occurs
in the cytoplasm of liver and intestinal
cells. Its synthesis starts with the con-
densation of three acetate molecules to
hydroxymethylglutarate by the action of
the rate-limiting enzyme hydroxyme-
thylglutaryl-coenzyme A (HMGCoA) re-
ductase. Hydroxymethylglutarate is then
reduced to mevalonate, which in turn is
decarboxylated to a 5-carbon isoprenoid.3, March 13, 2013 ª2013 Elsevier Inc. 245
Figure 1. GP63 Disrupts Cholesterol Metabolism through DICER1
Cleavage
In hepatocytes of a noninfected liver, pri-miR-122 in the nucleus is processed
by Drosha into pre-miR-122, which is then transported to the cytoplasm.
Pre-miR-122 is further processed by DICER1 and AGO2 into mature miR-
122, thence forming miRNP-122. This ribonucleoprotein regulates many
enzymes that modulate cholesterol metabolism. During Leishmania infection,
hepatocytes internalize exosomes containing the parasite metalloprotease
GP63, which cleaves DICER1, leading to an accumulation of pre-miR-
122. The consequential disruption in cholesterol metabolism ensues in
hypocholesterolemia.
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PreviewsCondensation of six mole-
cules of isoprenoids leads to
squalene, which is cyclized
into lanosterol by oxidosqua-
lene cyclase. Through a
19-step process, lanosterol
is finally processed into
cholesterol.
Cholesterol metabolizing
enzymes are stringently regu-
lated at many stages. At the
posttranscriptional level, mi-
croRNAs (miRNAs) regulate
genes involved in cholesterol
synthesis, efflux, and catabo-
lism. miRNA genes are tran-
scribed as long ‘‘pri-miRNA’’
precursors (Rotllan and Fer-
na´ndez-Hernando, 2012). In
animals, these precursors
are cleaved in the nucleus
by a complex called Micro-
processor, which is formed
by enzymes Drosha and
DGCR8. The intermediate
product, or ‘‘pre-mRNA,’’ is
a molecule of 70 nucleo-
tides long that is bent
into an imperfect stem loop
by means of complementarybase pairing. Pre-miRNAs are then trans-
ported to the cytosol via exportin 5. In the
cytosol, pre-miRNAs are cleaved by an
enzyme of the Dicer family (e.g., DICER1),
allowing the hydrolysis of the loop struc-
ture to release a small dsRNA strand
called duplex miRNA/miRNA. These in
turn interact with Argonaute family
proteins (AGO1 or AGO2) to form the
RNA-induced silencing (RISC) complex,
a type of miRNA ribonucleoprotein
(miRNP). miRNPs then repress protein
expression by impeding translation or by
mediating degradation of target mRNAs.
Each cell type has a different miRNA
pool. In liver, miR-122 accounts for 70%
of miRNAs and is a key player in choles-
terol metabolism, liver inflammation, and
carcinogenesis (Wen and Friedman,
2012). An accumulating body of evidence
has implicated cholesterol in the host-
pathogen interaction; lipid rafts, which
are signaling clusters enriched in choles-
terol, are used by a myriad of pathogens
to gain entry into host cells. For instance,
intact lipid rafts are required for Leish-
mania-mediated phagolysosome attenu-
ation (Winberg et al., 2009). Amazingly,
Leishmania also extracts cholesterol246 Cell Host & Microbe 13, March 13, 2013from macrophage membranes, resulting
in decreased capacity to stimulate
T cells (Chakraborty et al., 2005). It is
therefore tempting to infer that Leish-
mania could also tamper with cholesterol
biosynthesis to improve its own survival.
Ghosh and colleagues elegantly show
that Leishmania sabotages cholesterol
metabolism through GP63-mediated
cleavage of DICER1. This in turn hinders
miR-122 maturation, therefore ensuing in
decreased serum cholesterol and aug-
mented parasitemia in the liver (Figure 1).
Interestingly, the authors observed that
mice also suffered from a gradual postin-
fection decrease in cholesterol and other
blood lipids. To find the cause of this
phenotype, whole-genome microarray
analyses of infected liver were performed.
The resulting data revealed clusters of
upregulated and downregulated genes,
many of which were involved in lipid
metabolism. After validation, the authors
found that genes encoding for proteins
such as HMGCoA were severely downre-
gulated. Of utmost importance was the
fact that the presence of mature miR-
122 was inhibited by infection. In addition,
the authors found that exogenous expres-ª2013 Elsevier Inc.sion of miR-122 reduced
parasite burden in liver.
The authors discovered
that the factor responsible for
miR-122 inhibition lay within
Leishmania-derived exo-
somes, which are known to
be enriched in GP63 (Silver-
man and Reiner, 2011). This
GPI-anchored zinc-depen-
dent metalloprotease is a
pathogenesis factor that pro-
mastigotes use to modulate
macrophage responses to
infection (Isnard et al., 2012).
Upon incubating these exo-
somes with anti-GP63 anti-
bodies or with phenanthroline
(an inhibitor of zinc-depen-
dent metalloproteases), the
authors found that miR-122
inhibition was abolished.
Ghosh and colleagues also
noticed accumulation in miR-
122 precursors and found
that mature miR-122 failed to
get loaded onto AGO2, which
is necessary for miRNP
formation. These results
prompted the examination ofDICER1, which was found to be cleaved
by GP63 in vitro. Such cleavage was also
abolished by GP63 inhibition. To further
support their argument, exogenous
expression of DICER1 in infected mice
also abolished parasitemia and reconsti-
tuted serum cholesterol to near-normal
levels. Although these results strongly
support a role for GP63 in the cleavage
of DICER1 and the inhibition of miR-
122, they remain indirect evidence.
It will thus be crucial to generate
L. donovani gp63 knockout mutants to
directly ascertain the importance of
GP63 in the alteration of serum choles-
terol in experimental VL. This genetic
approach was instrumental in assessing
the role of GP63 in the pathogenesis of
L. major (Isnard et al., 2012; Joshi et al.,
2002). How GP63 exits infected liver
macrophages and enters neighboring
hepatocytes to cleave DICER1 is another
issue that will clearly deserve further
investigation. The fact that amastigotes
are present within phagolysosomes
suggests that GP63 must be released
from the parasite, cross the membrane
of the parasitophorous vacuole, get out
of the infected cells, enter hepatocytes,
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Previewsand finally access DICER1. Elucidating
this process is critical to our under-
standing of the pathology associated to
visceral leishmaniasis.
It is important to point out that, although
absence of miRNP-122 in liver results in
diminished serum cholesterol due to
decreased synthesis of HMGCoA re-
ductase, this also leads to augmented
cytoplasmic triglyceride accumulation
through upregulation of FSP27 (Wen and
Friedman, 2012). This protein, a direct
target of miR-122, is a negative regulator
of lipolysis and promotes triglyceride build
up. Hence, it is possible that increased
FSP27 in Leishmania-infected liver could
promote triglyceride accumulation and
gradual steatohepatitis. Furthermore,
miR-122absence results in liver inflamma-
tion, increased cytokine secretion, and
carcinogenesis. This raises the intriguing
possibility that GP63-mediated cleavage
of DICER1 could play a primordial role in
hepatocyte-mediated liver inflammation.
Though the authors clearly showed
that reconstitution of miR-122 or DICER1vastly decreases parasite burden, cleav-
age of DICER1 certainly has a more pro-
found impact on liver pathology. DICER1
regulates the maturation of a panoply of
miRNAs that also modulate liver homeo-
stasis and function. For example, it
would be of interest to elucidate the
effect of Leishmania on miR-33, which
regulates cholesterol efflux and fatty
acid oxidation (Rotllan and Ferna´ndez-
Hernando, 2012). Moreover, whether
DICER1 degradation affects the
pathology of cutaneous and mucocuta-
neous leishmaniasis by tampering with
miRNA pools in dermal cells and macro-
phages is an attractive hypothesis that
deserves attention.
In sum, Ghosh and colleagues convinc-
ingly show that Leishmania donovani
lowers serum cholesterol by hindering
the maturation of miR-122 via cleavage
of DICER1. This GP63-mediated effect
opens very exciting possibilities for inves-
tigating how Leishmania affects the host’s
miRNApool tocausediseaseandpromote
the parasite’s success.Cell Host & Microbe 1REFERENCES
Chakraborty, D., Banerjee, S., Sen, A., Banerjee,
K.K., Das, P., and Roy, S. (2005). J. Immunol.
175, 3214–3224.
Ghosh, J., Bose, M., Roy, S., and Bhattacharyya,
S. (2013). Cell Host Microbe 13, this issue,
277–288.
Isnard, A., Shio, M.T., and Olivier, M. (2012). Front.
Cell Infect. Microbiol. 2, 72.
Joshi, P.B., Kelly, B.L., Kamhawi, S., Sacks, D.L.,
and McMaster, W.R. (2002). Mol. Biochem.
Parasitol. 120, 33–40.
Lal, C.S., Kumar, A., Kumar, S., Pandey, K., Kumar,
N., Bimal, S., Sinha, P.K., and Das, P. (2007). Clin.
Chim. Acta 382, 151–153.
Rotllan, N., and Ferna´ndez-Hernando, C. (2012).
Cholesterol 2012, 847849.
Silverman, J.M., and Reiner, N.E. (2011). Front.
Cell Infect. Microbiol. 1, 26.
Simons, K., and Ikonen, E. (2000). Science 290,
1721–1726.
Wen, J., and Friedman, J.R. (2012). J. Clin. Invest.
122, 2773–2776.
Winberg, M.E., Holm, A., Sa¨rndahl, E., Vinet, A.F.,
Descoteaux, A., Magnusson, K.E., Rasmusson,
B., and Lerm, M. (2009). Microbes Infect. 11,
215–222.RIG-I Goes Beyond Naked RecognitionJ. Bradford Bowzard,1 Priya Ranjan,1 and Suryaprakash Sambhara1,*
1Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
*Correspondence: ssambhara@cdc.gov
http://dx.doi.org/10.1016/j.chom.2013.02.012
It is currently unclear at which point during viral replication that RNA genomes are first recognized as nonself
by the immune system. In this issue of Cell Host & Microbe, Weber et al. show that incoming nucleocapsid-
bound genomes are sufficient to bind and activate innate immune sensors.In the constant struggle between patho-
gens and their hosts, the evolution of the
immune system was a critical turning
point. Most vertebrates can mount adap-
tive immune responses in which specific
recognition of the invading microbe often
leads to long-term protection from rein-
fection. In contrast, almost all living
organisms exhibit some form of innate
immunity. The innate immune system
provides a more generic and limited
response to infection and, in vertebrates,
serves to augment the subsequent adap-tive response. The effectors of the innate
immune response include many types of
receptors, both membrane bound and
soluble in the cytoplasm and extracellular
milieu, which bind to structural motifs
known as pathogen-associated molec-
ular patterns (PAMPs) (Janeway and
Medzhitov, 2002). One of the more well
studied of these groups of pathogen
recognition receptors (PRRs) is the family
of RIG-I-like proteins, consisting of RIG-I,
MDA5, and LGP2, that recognize viral
PAMPs. Although these molecules haveclosely related sequences and structures,
they recognize PAMPs from different
viruses. For example, MDA5 can interact
with long double-stranded RNA (dsRNA)
and is important for resistance to picorna-
virues (Kato et al., 2006). In contrast, RIG-I
can interact with short dsRNA, as well as
both single- and double-stranded RNA
containing a 50 triphosphate (50 PPP)
group, and is critical for the response to
infection by influenza and other negative
sense single-stranded RNA viruses (Kato
et al., 2006). Ligand-receptor binding3, March 13, 2013 ª2013 Elsevier Inc. 247
